Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
Uveal melanoma is an aggressive cancer that metastasizes to the liver in about half of the patients, with a high lethality rate. Identification of patients at high risk of metastases may provide indication for a frequent follow-up for early detection of metastases and treatment. The analysis of the...
Main Authors: | Rosaria Gangemi, Valentina Mirisola, Gaia Barisione, Marina Fabbi, Antonella Brizzolara, Francesco Lanza, Carlo Mosci, Sandra Salvi, Marina Gualco, Mauro Truini, Giovanna Angelini, Simona Boccardo, Michele Cilli, Irma Airoldi, Paola Queirolo, Martine J Jager, Antonio Daga, Ulrich Pfeffer, Silvano Ferrini |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22267972/pdf/?tool=EBI |
Similar Items
-
Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met Inhibition
by: Adriana Amaro, et al.
Published: (2020-06-01) -
Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives
by: Michela Croce, et al.
Published: (2019-06-01) -
A PDZ Protein MDA-9/Syntenin: As a Target for Cancer Therapy
by: Yongsheng Yu, et al.
Published: (2019-01-01) -
MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells
by: Sarmistha Talukdar, et al.
Published: (2019-12-01) -
Downregulation of stromal syntenin sustains AML development
by: Raphael Leblanc, et al.
Published: (2023-11-01)